Read more about FDA Seeking Comments on Olaparib by June 11
May 22, 2014
FDA Seeking Comments on Olaparib by June 11
...for women with platinum-sensitive relapsed ovarian cancer (including fallopian tube or primary peritoneal) with germline BRCA mutation as detected by an FDA-approved test, who are in response (complete response or...